Role of carcinoma-associated fibroblasts and hypoxia in tumor progression

Current Topics in Microbiology and Immunology

Volumn 345, Issue 1, 2010, Pages 31-45

  Giaccia, Amato J ^a   Schipani, Ernestina ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD11B ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; COLLAGEN TYPE 1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; ENDOTHELIN 1; FIBROBLAST GROWTH FACTOR 2; FIBRONECTIN; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN P53; RANTES; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA1; UBIQUITIN PROTEIN LIGASE E3; VASCULOTROPIN; VIMENTIN;

ARTICLE; BONE MARROW; BREAST CARCINOMA; CANCER RADIOTHERAPY; CARCINOMA ASSOCIATED FIBROBLAST; CELL ACTIVITY; CELL DIFFERENTIATION; CELL HYPOXIA; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FIBROBLAST; FIBROCYTE PROGENITOR CELL; HEMATOPOIETIC STEM CELL; HUMAN; MACROPHAGE; MESENCHYMAL STEM CELL; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL; THERAPY EFFECT; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; ANIMAL; DISEASE COURSE; NEOPLASM; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; CELL DIFFERENTIATION; CELL HYPOXIA; DISEASE PROGRESSION; FIBROBLASTS; HUMANS; NEOPLASMS;

EID: 78349297892     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82-2010-73     Document Type: Article

References (113)

1. Aharinejad S, Sioud M et al (2009) Targeting stromal-cancer cell interactions with siRNAs. Methods Mol Biol 487:243-266
2. Ahmed F, Steele JC et al (2008) Tumor stroma as a target in cancer. Curr Cancer Drug Targets 86:447-453
3. Albini A, Sporn MB (2007) The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 72:139-147 (Pubitemid 46160989)
4. Anton K, Glod J (2009) Targeting the tumor stroma in cancer therapy. Curr Pharm Biotechnol 102:185-191
5. Asahara T, Takahashi T et al (1999) VEGF contributes to postnatal vascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18:3964-3972 (Pubitemid 29335849)
6. Baglole CJ, Ray DM et al (2006) More than structural cells, fibroblasts create and orchestrate the tumor microenvironment. Immunol Invest 353-4:297-325 (Pubitemid 44266778)
7. Balkwill F, Coussens LM (2004) Cancer: an inflammatory link. Nature 4317007:405-406 (Pubitemid 39329565)
8. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 3579255:539-545 (Pubitemid 32173595)
9. Barth PJ, Westhoff CC (2007) CD34+ fibrocytes: morphology, histogenesis and function. Curr Stem Cell Res Ther 23:221-227 (Pubitemid 47496606)
10. Barth PJ, Schenck zu Schweinsberg T et al (2004) CD34+ fibrocytes, alpha-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx. Virchows Arch 4443:231-234 (Pubitemid 38446434)
11. Bellini A, Mattoli S (2007) The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest 879:858-870 (Pubitemid 47267815)
12. Berra E, Benizri E et al (2003) HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. Embo J 2216:4082-4090 (Pubitemid 37021737)
13. Bhowmick NA, Chytil A et al (2004) TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 3035659:848-851 (Pubitemid 38174665)
14. Bianco P, Robey P et al (2008) Mesenchymal stem cells: revisiting history, concepts and assays. Cell Stem Cell 2:313-319 (Pubitemid 351467394)
15. Bishop T, Lau K et al (2004) Genetic analysis of pathways regulated by the von hippel-lindau tumor suppressor in Caenorhabditis elegans. PLoS Biol 2:e289
16. Bissell MJ, Radisky DC et al (2002) The organizing principle: microenvironmental influences in the normal and malignant breast. Differentiation 709-10:537-546 (Pubitemid 36194318)
17. Bucala R, Spiegel LA et al (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 11:71-81
18. Bunn HF, Poyton RO (1996) Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 763:839-885 (Pubitemid 26286080)
19. Caplan A (2007) Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213:341-347 (Pubitemid 47509711)
20. Chan D, Suthphin P et al (2002) Role of prolyl hydroxylation in oncogenically stabilized hyoxiainducible factor-1alpha. J Biol Chem 277:40112-40117 (Pubitemid 35191002)
21. Chan D, Sutphin P et al (2005) Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 alpha. Mol Cell Biol 25:6415-6426 (Pubitemid 41023218)
22. Chan DA, Krieg AJ et al (2007) HIF gene expression in cancer therapy. Methods Enzymol 435:323-345
23. Chometon G, Jendrossek V (2009) Targeting the tumour stroma to increase efficacy of chemo-and radiotherapy. Clin Transl Oncol 112:75-81
24. Cosse JP, Michiels C (2008) Tumour hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression. Anticancer Agents Med Chem 87:790-797
25. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 4206917:860-867 (Pubitemid 36019639)
26. Coussens LM, Tinkle CL et al (2000) MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 1033:481-490
27. De Wever O, MareelM(2003) Role of tissue stroma in cancer cell invasion. J Pathol 2004:429-447 (Pubitemid 36818244)
28. De Wever O, Demetter P et al (2008) Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer 12310:2229-2238
29. DeNardo DG, Barreto JB et al (2009) CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 162:91-102
30. Denko N, Fontana L et al (2003) Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 22:5907-5914 (Pubitemid 37176711)
31. Direkze NC, Hodivala-Dilke K et al (2004) Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res 6423:8492-8495 (Pubitemid 39552057)
32. Direkze NC, Jeffery R et al (2006) Bone marrow-derived stromal cells express lineage-related messenger RNA species. Cancer Res 663:1265-1269 (Pubitemid 43259902)
33. Dong J, Grunstein J et al (2004) VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumorigenesis. Embo J 2314:2800-2810 (Pubitemid 39013552)
34. Dvorak HF (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 31526:1650-1659 (Pubitemid 17052899)
35. Erler J, Bennewith K et al (2006) Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440:1222-1226
36. Erler JT, Bennewith KL et al (2009) Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 151:35-44
37. Feldman DE, Chauhan V et al (2005) The unfolded protein response: a novel component of the hypoxic stress response in tumors. Mol Cancer Res 311:597-605 (Pubitemid 41780915)
38. Feldon SE, O'Loughlin CW et al (2006) Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes. Am J Pathol 1694:1183-1193 (Pubitemid 351194355)
39. Friedenstein A (1980) Stromal mechanisms of bone marrow: cloning in vitro and retransplantation in vivo. Haematol Blood Transf 25:19-29
40. Friedenstein A, Chailakhjan R et al (1970) The development of fibroblast colonies in monolayer cutures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393-403
41. Fukumura D, Xavier R et al (1998) Tumor induction of VEGF promoter activity in stromal cells. Cell 946:715-725 (Pubitemid 28436004)
42. Gaggioli C, Hooper S et al (2007) Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 912:1392-1400 (Pubitemid 350201752)
43. Giaccia A, Siim B et al (2003) HIF-1 as a target for drug development. Nat Rev Drug Discov 2:803-811 (Pubitemid 37361812)
44. Giaccia AJ, Simon MC et al (2004) The biology of hypoxia: the role of oxygen sensing in development, normal function, and disease. Genes Dev 1818:2183-2194 (Pubitemid 39209567)
45. Graeber TG, Osmanian C et al (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 3796560:88-91 (Pubitemid 26008141)
46. Greijer AE, van der Groep P et al (2005) Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol 2063:291-304 (Pubitemid 40903193)
47. Hall E, Giaccia AJ (2006) Radiobiology for the radiologist. Lippincott Williams & Wilkins, Philadelphia
48. Hall B, AndreeffMet al (2007) The participation ofmesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles. Handb Exp Pharmacol 180:263-283
49. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 1001:57-70 (Pubitemid 30046295)
50. Hartlapp I, Abe R et al (2001) Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. Faseb J 1512:2215-2224 (Pubitemid 32927939)
51. Hayashida K, Fujita J et al (2005) Bone marrow-derived cells contribute to pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension. Chest 1275:1793-1798 (Pubitemid 46218809)
52. Higgins DF, Kimura K et al (2008) Hypoxia-inducible factor signaling in the development of tissue fibrosis. Cell Cycle 79:1128-1132 (Pubitemid 351749261)
53. Hill R, Song Y et al (2005) Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell 1236:1001-1011 (Pubitemid 41785416)
54. Hong KM, Belperio JA et al (2007) Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma. J Biol Chem 28231:22910-22920 (Pubitemid 47267358)
55. Hughes CC (2008) Endothelial-stromal interactions in angiogenesis. Curr Opin Hematol 153:204-209 (Pubitemid 351507572)
56. Ishii G, Sangai T et al (2003) Bone-marrow-derived myofibroblasts contribute to the cancerinduced stromal reaction. Biochem Biophys Res Commun 3091:232-240 (Pubitemid 37006422)
57. Ivan M, Kondo K et al (2001) HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: imlications for O2 sensing. Science 292:464-468 (Pubitemid 32335941)
58. Jaakkola P, Mole D et al (2001) Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292:468-472 (Pubitemid 32335942)
59. Jiang YL, Dai AG et al (2006) Transforming growth factor-beta1 induces transdifferentiation of fibroblasts into myofibroblasts in hypoxic pulmonary vascular remodeling. Acta Biochim Biophys Sin (Shanghai) 381:29-36
60. Kaelin W (2002) How oxygen makes its presence felt. Genes Dev 16:1441-1445
61. Kallio PJ, Okamoto K et al (1998) Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha. Embo J 1722:6573-6586 (Pubitemid 28521792)
62. Kallio PJ, Wilson WJ et al (1999) Regulation of the Hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J Biol Chem 27410:6519-6525 (Pubitemid 29111068)
63. Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 65:392-401
64. Karnoub AE, Dash AB et al (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 4497162:557-563 (Pubitemid 47525152)
65. Kiaris H, Trimis G et al (2008) Regulation of tumor-stromal fibroblast interactions: implications in anticancer therapy. Curr Med Chem 1529:3062-3067
66. Kolf C, Cho E et al (2007) Biology of adult mesenchymal stem cells: regulation of niche, selfrenewal and differentiation. Arthritis Res Ther 9:204
67. Koukourakis MI, Giatromanolaki A et al (2006) Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumorassociated stroma. Cancer Res 662:632-637 (Pubitemid 43165922)
68. Koyama H, Kobayashi N et al (2008) Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis: pivotal role of a hyaluronan-rich tumor microenvironment. Am J Pathol 1721:179-193 (Pubitemid 351186379)
69. Leo C, Giaccia A et al (2004) The hypoxic tumor microenvironment and gene expression. Semin Radiat Oncol 14:207-214 (Pubitemid 38903224)
70. Liotta LA, Kohn EC (2001) The microenvironment of the tumour-host interface. Nature 4116835:375-379
71. Liu L, Simon MC (2004) Regulation of transcription and translation by hypoxia. Cancer Biol Ther 36:492-497 (Pubitemid 41351114)
72. Lorusso G, Ruegg C (2008) The tumor microenvironment and its contribution to tumor evolution toward metastasis. Histochem Cell Biol 1306:1091-1103
73. Masson R, Lefebvre O et al (1998) In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J Cell Biol 1406:1535-1541 (Pubitemid 28153000)
74. Maxwell P, Wiesener M et al (1999) The tumour suppressor protein VHL targets hypoxiainducible factors for oxygen-dependent proteolysis. Nature 399:271-275 (Pubitemid 29246458)
75. Mehrad B, Burdick MD et al (2009) Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis. Int J Biochem Cell Biol 418-9:1708-1718
76. Metz CN (2003) Fibrocytes: a unique cell population implicated in wound healing. Cell Mol Life Sci 607:1342-1350 (Pubitemid 36900518)
77. Milas L, Hirata H et al (1988) Effect of radiation-induced injury of tumor bed stroma on metastatic spread of murine sarcomas and carcinomas. Cancer Res 488:2116-2120
78. Min J, Yang H et al (2002) Structure of an HIF-1alpha-pVHL complex: hydroxyproline recognition in signaling. Science 296:1886-1889 (Pubitemid 34596278)
79. Monnier Y, Farmer P et al (2008) CYR61 and alphaVbeta5 integrin cooperate to promote invasion and metastasis of tumors growing in preirradiated stroma. Cancer Res 6818:7323-7331
80. Mueller MM, Fusenig NE (2004) Friends or foes -bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 411:839-849 (Pubitemid 39472951)
81. Nazareth MR, Broderick L et al (2007) Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells. J Immunol 1789:5552-5562 (Pubitemid 46674350)
82. Olumi AF, Grossfeld GD et al (1999) Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 5919:5002-5011 (Pubitemid 29472907)
83. Orimo A, Weinberg RA (2006) Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 515:1597-1601 (Pubitemid 44285243)
84. Orimo A, Gupta PB et al (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 1213:335-348 (Pubitemid 40692295)
85. Pahler JC, Tazzyman S et al (2008) Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response. Neoplasia 104:329-340
86. Patocs A, Zhang L et al (2007) Breast-cancer stromal cells with TP53 mutations and nodal metastases. N Engl J Med 35725:2543-2551 (Pubitemid 350294221)
87. Phillips RJ, Burdick MD et al (2004) Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 1143:438-446 (Pubitemid 39071616)
88. Pietras K, Pahler J et al (2008) Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting. PLoS Med 51:e19
89. Pittenger M, Mackay A et al (1999) Multiineage potential of adult human mesenchymal stem cells. Science 284:143-147 (Pubitemid 29282067)
90. Pouyssegur J, Dayan F et al (2006) Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 4417092:437-443 (Pubitemid 44050138)
91. Prockop D (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74 (Pubitemid 27161245)
92. Quan TE, Bucala R (2007) Culture and analysis of circulating fibrocytes. Methods Mol Med 135:423-434
93. Quan TE, Cowper S et al (2004) Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 364:598-606 (Pubitemid 38316817)
94. Rankin EB, Giaccia AJ (2008) The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 154:678-685 (Pubitemid 351405072)
95. Schipani E, Kronenberg HM (2008) Adult mesenchymal stem cells. Stembook doi:10.3824/ stembook.1.38.1
96. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 310:721-732 (Pubitemid 37328811)
97. Semenza GL (2009) Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Semin Cancer Biol 191:12-16
98. Shan W, Yang G et al (2009) The inflammatory network: bridging senescent stroma and epithelial tumorigenesis. Front Biosci 14:4044-4057
99. Stover DG, Bierie B et al (2007) A delicate balance: TGF-beta and the tumor microenvironment. J Cell Biochem 1014:851-861 (Pubitemid 47040867)
100. Tan TT, Coussens LM (2007) Humoral immunity, inflammation and cancer. Curr Opin Immunol 192:209-216 (Pubitemid 46356960)
101. Tlsty TD, Coussens LM (2006) Tumor stroma and regulation of cancer development. Annu Rev Pathol 1:119-150
102. Trimboli AJ, Cantemir-Stone CZ et al (2009) Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 4617267:1084-1091
103. van Deventer HW, Wu QP et al (2008) C-C chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9. Am J Pathol 1731:253-264 (Pubitemid 351947972)
104. van Kempen LC, Coussens LM (2002) MMP9 potentiates pulmonary metastasis formation. Cancer Cell 24:251-252 (Pubitemid 41043957)
105. Wang GL, Semenza GL (1993) General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA 909:4304-4308 (Pubitemid 23134215)
106. Wang GL, Jiang BH et al (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 9212:5510-5514
107. Weinberg RA (2007) The Biology of Cancer 1st Edition Chapter 13:527-586. Garland Science Publisher, NY, USA
108. Wels J, Kaplan RN et al (2008) Migratory neighbors and distant invaders: tumor-associated niche cells. Genes Dev 225:559-574 (Pubitemid 351342429)
109. Wenger RH, Rolfs A et al (1997) The mouse gene for hypoxia-inducible factor-1alpha-genomic organization, expression and characterization of an alternative first exon and 5' flanking sequence. Eur J Biochem 2461:155-165 (Pubitemid 27229682)
110. Wouters BG, Koritzinsky M (2008) Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer 811:851-864
111. Wykoff C, Pugh C et al (2000) Identification of novel hypoxia dependent and independent target genes of the von Hippel Lindau (VHL) tumor suppressor by mRNA differential expression profiling. Oncogene 19:6297-6305 (Pubitemid 32641843)
112. Wynn TA (2008) Cellular and molecular mechanisms of fibrosis. J Pathol 2142:199-210 (Pubitemid 351160157)
113. Zumsteg A, Christofori G (2009) Corrupt policemen: inflammatory cells promote tumor angiogenesis. Curr Opin Oncol 211:60-70